Home 2022

Archives

emerging health concerns, diagnostics

Novacyt is powering ahead and tackling emerging health concerns

Empowering employees and examining emerging health threats in a new strategy for business growth is Novacyt CEO David Allmond’s mission in the weeks ahead.
laboratory workflow testing, covid-19

Innovative automation supports laboratory testing workflow

Global clinical diagnostics company Novacyt introduce a new automated liquid handling system to meet growing demand for no manual pipetting in COVID-19 PCR testing.
covid rapid testing, respiratory viruses

Rapid testing to differentiate between COVID-19 & other infections

Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.

Clinical diagnostics revolution set to boost patient outcomes

Here, we learn how international diagnostics group Novacyt are leading the innovation revolution in clinical diagnostics through discovery, design, and innovation.
SARS-CoV-2 variant

Global bioinformatics surveillance: SARS-CoV-2 variant detection tests

Shiao Yee, Marketing Communications Manager, Novacyt Group, discusses how global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests.
the evolution of testing, novacyt

COVID-19: The evolution of testing & sequencing

Novacyt Group, discusses the evolution of testing and sequencing during COVID-19 with a panel of distinguished speakers.

Follow Us

Advertisements